A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease
- 1 June 2020
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 189, 101789
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01NS082283)
- Sanford Research and Charles River Laboratories
This publication has 77 references indexed in Scilit:
- Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosisBiology Open, 2013
- Evaluation of Neurodegeneration in a Mouse Model of Infantile Batten Disease by Magnetic Resonance Imaging and Magnetic Resonance SpectroscopyNeurodegenerative Diseases, 2012
- An Introduction to Diffusion Tensor Image AnalysisNeurosurgery Clinics of North America, 2011
- Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease)Neurochemistry International, 2009
- Molecular correlates of axonal and synaptic pathology in mouse models of Batten diseaseHuman Molecular Genetics, 2009
- Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosisBrain Research, 2009
- Location and connectivity determine GABAergic interneuron survival in the brains of South Hampshire sheep with CLN6 neuronal ceroid lipofuscinosisNeurobiology of Disease, 2008
- Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repairPharmacology & Therapeutics, 2008
- N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiologyProgress in Neurobiology, 2007
- Effects of Alzheimer Disease on Fronto-parietal Brain N-acetyl Aspartate and Myo-Inositol Using Magnetic Resonance Spectroscopic ImagingAlzheimer Disease & Associated Disorders, 2006